Abstract
Elucidation of the biology of feline oncoretroviruses over the past 20 years has changed the concepts of retroviruses in all animals, including humans. This chapter considers the history, virology, epidemiology, immune responses, pathology, and vaccination of feline oncoretroviruses.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abelson, H. T., and Rabstein, L. S., 1970, Lymphosarcoma, virus-induced thymic independent disease in mice, Cancer Res. 30:2213.
Abkowitz, J. L., Holly, R. D., and Adamson, J. W., 1987, Retrovirus-induced feline pure red cell aplasia: The kinetics of marrow failure, J. Cell Physiol. 132:571.
Akerblom, L., Stromstedt, K., Hoglund, S., Osterhaus, A., and Morein, B., 1989, Formation and characterization of FeLV ISCOMS, Vaccine 7:142.
Aldrich, C. D., and Pedersen, N. C. 1974, Persistent viremia after regression of primary virus-induced feline fibrosarcomas, Am. J. Vet. Res. 35:1383.
Anderson, L. J., Jarrett, W. F. H., Jarrett, O., and Laird, H. M., 1971, Feline leukemia-virus infection of kittens: Mortality associated with atrophy of the thymus and lymphoid depletion, J. Natl. Cancer Inst. 47:807.
Anderson, S. J., Furth, M., Wolff, L., Ruscetti, S. K., and Sherr, C. J., 1982, Monoclonal antibodies to the transformation specific glycoprotein encoded by the feline retroviral oncogene v-fms. J. Virol. 44:696.
Anderson, D. M., Lyman, S. D., Baird, A., Wignall, J. M., Eisenman, J., Rauch, C., March, C. J., Boswell, H. S., Gimpel, S. D., Cosman, D., and Williams, D. E., 1990, Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235.
Aziz, D. C., Hanna, Z., and Jolicoeur, P., 1989, Severe immunodeficiency disease induced by a defective murine leuaemia virus, Nature 338:505.
Baluda, M. A., and Roy-Burman, P., 1973, Partial characterization of RD-114 virus by DNA-RNA hybridization studies, Nature 244:59.
Barbacid, M., Lauver, A. V., and Devare, S. G., 1980, Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus, J. Virol. 33:196.
Benveniste, R. E., and Todaro, G. J., 1973, Homology between type-G viruses of various species as determined by molecular hybridization, Proc. Natl. Acad. Sci. USA 70:3316.
Benveniste, R. E., Sherr, C. J., and Todaro, G. J., 1975, Evolution of type C viral genes: Origin of feline leukemia virus, Science 190:886.
Bergold, P. J., Wang, J. Y. J., Hardy, W. D., Jr., Littau, V., Johnson, E., and Besmer, P., 1987, Structure and origins of the HZ2-feline sarcoma virus, Virology 158:320.
Besmer, P., 1983, Acute transforming feline retroviruses, Curr. Top. Microbiol. Immunol. 107:1.
Besmer, P., Snyder, H. W., Jr., Murphy, J. E., Hardy, W. D., Jr., and Parodi, A., 1983a, The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes, J. Virol. 46:606.
Besmer, P., Hardy, W. D., Jr., Zuckerman, E. E., Bergold, P., Lederman, L., and Snyder, H. W., Jr., 1983b, The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV, Nature 303:825.
Besmer, P., Lader, E., George, P., Bergold, P. J., Qui, F-H., Zuckerman, E. E., and Hardy, W. D., Jr., 1986a, A new acute transforming feline retrovirus with fms homology specifies a c-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein, J. Virol. 60:194.
Besmer, P., Murphy, J. E., George, P. C., Qui, F. H., Bergold, P. J., Snyder, H. W., Jr., Brodeur, D., Zuckerman, E. E., and Hardy, W. D., Jr., 1986b, A new acute transforming feline retrovirus and relationship of its oncogene kit with the protein kinase gene family, Nature 320:415.
Bishop, J. M., 1981, Enemies within: The genesis of retrovirus oncogenes, Cell 23:5.
Blue, J. T., 1988, Myelofibrosis in cats with myelodysplastic syndrome and acute myelogenous leukemia, Vet. Pathol. 25:154.
Bolognesi, D. P., Montelaro, R. C., Frank, H., and Schafer, W., 1978, Assembly of type C oncorna-viruses: A model, Science 199:183.
Bonham, L., Lobelle-Rich, P. A., Henderson, L. A., and Levy, L. S., 1987, Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells, J. Virol. 61:3072.
Bonner, T. I., and Todaro, G. J., 1979, Carnivores have sequences in their cellular DNA distantly related to the primate endogenous virus, Virology 94:224.
Boyce, J. T., Kociba, G. J., Jacobs, R. M., and Weiser, M. G., 1986, Feline leukemia virus-induced thrombocytopenia and macrothrombocytosis in cats, Vet. Pathol. 23:16.
Brodey, R. S., McDonough, S., Frye, F. L., and Hardy, W. D., Jr., 1970, Epidemiology of feline leukemia, in: Comparative Leukemia Research (R. M. Dutcher ed.), pp. 333–342, Karger, Basel.
Case, M. T., 1970, A case of myelogenous leukemia in the cat, Zentralbl Veterinarmed 17:273.
Casey, J. W., Roach, A., Mullins, J. T., Burck, K. B., Nicolson, M. O., Gardner, M. B., and Davidson, N., 1981, The U3 portion of the feline leukemia virus identifies horizontally acquired proviruses in leukemic cats, Proc. Natl. Acad. Sci. USA 78:7778.
Chapman, A. L., Weitlauf, H. M., and Bopp, W., 1974, Effect of feline leukemia virus on transferred hamster fetuses, J. Natl. Cancer Inst. 52:583.
Chattopadhyay, S. K., Cloyd, M. W., Linemeyer, D. L., Lander, M. R., Rands, E., and Lowy, D. R., 1982, Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas, Nature 295:25.
Clark, N., Kushner, N. N., Barrett, C., Kensil, C. R., Salsbury, D., and Cotter, S., 1991, Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection, J. Am. Vet. Med. Assoc. 199:1433.
Cockerell, G. L., and Hoover, E. A., 1977, Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats, Cancer Res. 37:3985.
Cockerell, G. L., Hoover, E. A., Krakowka, S., Olsen, R. G., and Yohn, D. S., 1976, Lymphocyte mitogen reactivity and enumeration of circulating B-and T-cells during feline leukemia virus infection in the cat, J. Natl. Cancer Inst. 57:1095.
Cole, G. E., Stacy-Phipps, S., and Nunberg, J. H., 1990, Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins, J. Virol. 64:4930.
Cotter, S. M., Hardy, W. D., Jr., and Essex, M., 1975, The association of the feline leukemia virus with lymphosarcoma and other disorders, J. Am. Vet. Med. Assoc. 166:449.
Crighton, G. W., 1969, Lymphosarcoma in the cat, Vet. Rec. 84:329.
Dameshek, W., 1951, Some speculations on the myeloproliferative syndromes, Blood 6:372.
Day, N. K., O’Reilly-Felice, C., Hardy, W. D., Jr., Good, R. A., and Witken, S. S., 1980, Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats, J. Immunol. 126:2363.
Deinhardt, F., Wolfe, L. G., Theilen, G. H., and Snyder, S. P., 1970, ST-feline fibrosarcoma virus: Induction of tumors in marmoset monkeys, Science 167:881.
Dezzutti, C. S., Lafrado, L. J., Lewis, M. G., and Olsen, R. G., 1990, Inhibition of phorbol ester-induced neutrophil chemiluminescence by FeLV, Arch. Virol. 111:75.
Donner, L., Turek, L. P., Ruscetti, S. K., Fedele, L. A., and Sherr, C. J., 1980, Transformation defective mutants of feline sarcoma virus which express a product of the viral src gene, J. Virol. 35:129.
Doolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., and Antoniades, H. N., 1983, Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor, Science 221:275.
Dorn, C. R., Taylor, D. O. N., Schneider, R., Hibbard, H. H., and Klauber, M. R., 1968, Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II: Cancer morbidity in dogs and cats from Alameda County, J. Natl. Cancer Inst. 40:307.
Dornsife, R. E., Gasper, P. W., Mullins, J. I., and Hoover, E. A., 1989, Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus, 1989, Lenk. Res. 13:745.
Dworkin, B. M., Rosenthal, W. S., Wormser, G. P., and Weiss, L., 1986, Selenium deficiency in the acquired immunodeficiency syndrome, J. Parenter. Nutr. 10:405.
Elder, J. H., and Mullins, J. T., 1983, Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus, J. Virol. 46:871.
Elder, J. H., Gautsch, J. W., Jensen, F. C., Lerner, R. A., Hartley, J. W., and Rowe, W. P., 1977, Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants, Proc. Natl. Acad. Sci. USA 74:4676.
Essex, M., 1980, Feline leukemia and sarcoma viruses, in: Viral Oncology (G. Klein, ed.), pp. 205–229, Raven Press, New York.
Essex, M., Klein, G., Snyder, S. P., and Harrold, J. B., 1971, Correlation between humoral antibody and regression of tumours induced by feline sarcoma virus, Nature 233:195.
Essex, M., Sliski, A., Cotter, S. M., Jakowski, R. M., and Hardy, W. D., Jr., 1975, Immunosurveillance of naturally occurring feline leukemia, Science 190:790.
Essex, M., Cotter, S. M., Sliski, A. H., Hardy, W. D., Jr., Stephenson, J. R., Aaronson, S. A., and Jarrett, O., 1977a, Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household, Int. J. Cancer, 19:90.
Essex, M., Cotter, S. M., Stephenson, J. R., Aaronson, S. A., and Hardy, W. D., Jr., 1977b, Leukemia, lymphoma and fibrosarcoma of cats as models for similar diseases of man, in: Origins of Human Cancer (H. W. Hiatt, J. D. Watson, and J. A. Winston eds.), pp. 1197–1214, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Fischinger, P. G., Pebbles, P. T., Nomura, S., and Haapala, D. K., 1973, Isolation of RD-114-like oncornavirus from cat cell lines, J. Virol. 11:978.
Flanagan, J. G., and Leder, P., 1990, The kit ligand: A cell surface molecule altered in steel mutant fibroblasts, Cell 63:185.
Forrest, D., Onions, D., Lees, G., and Neil, J. C., 1987, Altered structure and expression of c-myc in feline T-cell tumors, Virology 158:194.
Francis, D. P., Essex, M., and Hardy, W. D., Jr., 1977, Excretion of feline leukemia virus by naturally infected pet cats, Nature 269:252.
Francis, D. P., Cotter, S. M., Hardy, W. D., Jr., and Essex, M., 1979, Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma, Cancer Res. 39:3866.
Frankel, A. E., Gilbert, J. H., Porzig, F. J., Scolnick, E. M., and Aaronson, S. A., 1979, Nature and distribution of feline sarcoma virus nucleotide sequences, J. Virol. 30:821.
Fraser, C.J., Joiner, G. N., Jardine, J. H., and Gleiser, C. A., 1974, Acute granulocytic leukemia in cats, J. Am. Vet. Med. Assoc. 165:355.
Fujinami, A., and Inamoto, K., 1914, Ueber geschwulste bei japanischen haushuhnern insbesondere uber einen transplantablen tumor, Z. Krebsforsch 14:94.
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., and Markham, P. D., 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science 224:500.
Gardner, M. B., Arnstein, P., Rongey, R. W., Estes, J. D., Sarma, P. S., Rickard, C. F., and Huebner, R. J., 1970, Experimental transmission of feline fibrosarcoma to cats and dogs, Nature 226:807.
Gardner, M. B., Arnstein, P., Johnson, E., Rongey, R. W., and Charman, H. P., 1971a, Feline sarcoma virus tumor induction in cats and dogs, J. Am. Vet. Med. Assoc. 158:1046.
Gardner, M. B., Rongey, R. W., Johnson, F. V., De Journett, R., and Huebner, R. J., 1971b, C-type virus particles in salivary tissue of domestic cats, J. Natl. Cancer Inst. 47:561.
Gardner, M. B., Henderson, B. E., Officer, J. E., Rongey, R. W., Parker, J. C., Oliver, C., Estes, J. D., and Huebner, R. J., 1973, A spontaneous lower motor neuron disease apparently caused by indigenous type C RNA virus in wild mice, J. Natl. Cancer Inst. 51:1243.
Gardner, M. B., Brown, J. C., Charman, H. P., Stephenson, J. R., Rongey, R. W., Hauser, D. E., Diegmann, F., Howard, E., Dworsky, R., Gilden, R. V., and Huebner, R. J., 1977, FeLV epidemiology in Los Angeles cats: Appraisal of detection methods, Int. J. Cancer 19:581.
Gilbert, J. H., Pedersen, N. C., and Nunberg, J. H., 1987, Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: Apparent lack of immunogenicity in vaccinated animals, Virus Res. 7:49.
Glick, A. D., Horn, R. G., and Holscher, M., 1978, Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasms, Am. J. Pathol. 92:321.
Goff, S. P., and Baltimore, D., 1982, The cellular oncogene of the Abelson murine leukemia virus genome, in: Advances in Viral Oncology (G. Klein, ed.), pp. 127–139, Raven Press, New York.
Gottlieb, M., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., and Saxon, A., 1981, Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men, N. Engl J. Med. 305:1425.
Grundwald, D. J., Dale, B., Dudley, J., Lamph, W., Sugden, B., Ozanne, B., and Risser, R., 1982, Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells. J. Virol. 43:92.
Gwalter, R. H., 1981, FeLV-testmethoden, IFA order ELISA, Kleintier Praxis 26:23.
Haffer, K. N., Koertje, W. D., Derr, J. T. and Beckenhauer, W. H., 1990, Evaluation of immunosuppressive effect and efficacy of an improved-potency feline leukemia vaccine, Vaccine 8:12.
Hammar, L., Eriksson, S., Malm, K., and Morein, B., 1989, Concentration and purification of feline leukaemia virus (FeLV) and its outer envelope protein gp70 by aqueous two-phase systems, J. Virol. Methods 24:91.
Handsfield, H. H., 1985, Screening for HTLV-III antibody, N. Engl. J. Med. 313:888.
Hardy, W. D., Jr., 1980a, Feline leukemia virus disease, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 3–31, Elsevier, New York.
Hardy, W. D., Jr., 1980b, The biology and virology of the feline sarcoma viruses, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland eds.), pp. 79–118, Else-vier, New York.
Hardy, W. D., Jr., 1981a, Feline leukemia virus non-neoplastic diseases, J. Am. Anim. Hosp. Assoc. 17:941.
Hardy, W. D., Jr., 1981b, The feline leukemia virus, J. Am. Anim. Hosp. Assoc. 17:951.
Hardy, W. D., Jr., 1981c, The feline sarcoma viruses, J. Am. Anim. Hosp. Assoc. 17:981.
Hardy, W. D., Jr., 1981d, Hematopoietic tumors of cats, J. Am. Anim. Hosp. Assoc. 17:921.
Hardy, W. D., Jr., 1982, Immunopathology induced by the feline leukemia virus, in: Springer Semin. Immunopathol (G. Klein, ed.), pp. 75–105, Springer-Verlag, New York.
Hardy, W. D., Jr., 1983a, Naturally occurring retroviruses (RNA tumor viruses). I: Cancer Invest. 1:67.
Hardy, W. D., Jr., 1983b, Naturally occurring retroviruses (RNA tumor viruses). II: Cancer Invest. 1:163.
Hardy, W. D., Jr., 1984, Feline leukemia virus as an animal retrovirus model for the human T-cell leukemia virus, in: Human T-Cell Leukemia/Lymphoma Viruses (R. C. Gallo, M. Essex, and L. Gross, eds.), pp. 35–43, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Hardy, W. D., Jr., 1985, Feline retroviruses, in: Advances in Viral Oncology, Vol. 5. (G. Klein, ed.), pp. 1–34, Raven Press, New York.
Hardy, W. D., Jr., 1988, Feline T-lymphotropic lentivirus: Retrovirus-induced immunosuppression in cats, J. Am. Anim. Hosp. Assoc. 24:241.
Hardy, W. D., Jr., 1990, Biology of feline retroviruses, in: Retrovirus Biology and Human Disease (R. C. Gallo and F. Wong-Staal, eds.), pp. 33–86, Marcel Dekker, New York.
Hardy, W. D., Jr., 1991, General principles of retrovirus immunodetection tests, J. Am. Vet. Med. Assoc. 199:1282.
Hardy, W. D., Jr., and Essex, M., 1986, FeLV-Induced feline acquired immune deficiency syndrome (FAIDS): A model for human AIDS, in: Acquired Immune Deficiency Syndrome, Progress in Allergy 37 (E. Klein, ed.), pp. 353–376, Karger, Basel.
Hardy, W. D., Jr., and Zuckerman, E. E., 1991a, Development of the immunofluorescent antibody test for detection of feline leukemia virus infection in cats, J. Am. Vet. Med. Assoc. 199:1327.
Hardy, W. D., Jr., and Zuckerman, E. E., 1991b, Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescent antibody test for detection of feline leukemia virus infection in cats, J. Am. Vet. Med. Assoc. 199:1365.
Hardy, W. D., Jr., Geering, G., Old, L. J., deHarven, E., Brodey, R. S., and McDonough, S., 1969, Feline leukemia virus; occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases, Science 166:1019.
Hardy, W. D., Jr., Old, L. J., Hess, P. W., Essex, M., and Cotter, S., 1973a, Horizontal transmission of feline leukaemia virus, Nature 244:266.
Hardy, W. D., Jr., Hirshaut, Y., and Hess, P., 1973b, Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence, in: Unifying Concepts of Leukemia (R. M. Dutcher and L. Chieco-Bianchi, eds.), pp. 778–799, Karger, Basel.
Hardy, W. D., Jr., McClelland, A. J., Hess, P. W., and MacEwen, G., 1974, Veterinarians and the control of feline leukemia virus, J. Am. Anim. Hosp. Assoc. 10:367.
Hardy, W. D., Jr., Hess, P. W., MacEwen, E. G., McClelland, A. J., Zuckerman, E. E., Essex, M., Cotter, S. M., and Jarrett, O., 1976a, Biology of feline leukemia virus in the natural environment, Cancer Res. 36:582.
Hardy, W. D., Jr., McClelland, A. J., Zuckerman, E. E., Hess, P. W., Essex, M., Cotter, S. M., MacEwen, E. G., and Hayes, A. A., 1976b, Prevention of the contagious spread of feline leukaemia virus and the development of leukaemia in pet cats, Nature 263:326.
Hardy, W. D., Jr., Zuckerman, E. E., MacEwen, E. G., Hayes, A. A., and Essex, M., 1977, A feline leukaemia virus-and sarcoma virus-induced tumour-specific antigen, Nature 270:249.
Hardy, W. D., Jr., Zuckerman, E. E., Essex, M., MacEwen, E. G., and Hayes, A. A., 1978, Feline oncornavirus-associated cell-membrane antigen: An FeLV-and FeSV-induced tumorspecific antigen, in: Differentiation of Normal and Neoplastic Hematopoietic Cells (B. Clarkson, P. A. Marks, and J. E. Till, eds.), pp. 601–623, Cold Spring Laboratory, Cold Spring Harbor, NY.
Hardy, W. D., Jr., McClelland, A. J., Zuckerman, E. E., Snyder, H. W., Jr., MacEwen, E. G., Francis, D., and Essex, M., 1980a, Development of virus non-producer lymphosarcomas in pet cats exposed to FeLV, Nature 288:90.
Hardy, W. D., Jr., McClelland, A. J., Zuckerman, E. E., Snyder, H. W., MacEwen, E. G., Francis, D. P., and Essex, M., 1980b, Immunology and epidemiology of feline leukemia virus non-producer lymphosarcomas, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, and H. ZurHausen, eds.), pp. 677–697, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Hardy, W. D., Jr., MacEwen, E. G., Hayes, A. A., and Zuckerman, E. E., 1980c, FOCMA antibody as specific immunotherapy for lymphosarcoma of pet cats, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 227–233, Elsevier, New York.
Hardy, W. D., Jr., Zuckerman, E., Markovich, R., Besmer, P., and Snyder, H. W., 1982, Isolation of feline sarcoma viruses from pet cats with multicentric fibrosarcomas, in: Advances in Comparative Leukemia Research 1981 (D. S. Yohn and J. R. Blakeslee, eds.), pp. 205–206, Elsevier, North-Holland, New York.
Hardy, W. D., Jr., Zuckerman, E. E., Lehrman, S. N., and Barry, D. W., 1985, Anti-viral effects of BW A509U (AZT) against a naturally occurring feline acquired immunodeficiency syndrome (FAIDS)-inducing retrovirus, in: Abstracts of the Twenty-fifth Antimicrobial Agents and Chemotherapy, p. 171.
Hartley, J. W., Wolford, N. K., Old, L. J., and Rowe, W. P., 1977, A new class of murine leukemia virus associated with development of spontaneous lymphomas, Proc. Natl. Acad. Sci. USA 74:789.
Herz, A., Theilen, G. H., and Schalm, O. W., 1970, C-type virus in bone marrow cells of cats with myeloproliferative disorders, J. Natl. Cancer Inst. 44:339.
Hoover, E. A., 1984, Experimental studies of the pathogenesis of feline leukemia virus infection, in: RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS: On the Frontiers of Understanding (P. Furmanski, J. C. Hager, and M. A. Rich, eds.), pp. 267–288, Martinus Nijhoff, Boston.
Hoover, E. A., and Kociba, G. J., 1974, Bone lesions in cats with anemia induced by feline leukemia virus, J. Natl. Cancer Inst. 53:1277.
Hoover, E. A., Perryman, L. E., and Kociba, G. J., 1973, Early lesions in cats inoculated with feline leukemia virus, Cancer Res. 33:145.
Hoover, E. A., Kociba, G. J., Hardy, W. D., Jr., and Yohn, D. S., 1974, Erythroid hypoplasis in cats inoculated with feline leukemia virus, J. Natl. Cancer Inst. 53:1271.
Hoover, E. A., Olsen, R. G., Hardy, W. D., Jr., Schaller, J. P., and Mathes, L. E., 1976, Feline leukemia virus infection: Age related variation in response of cats to experimental infection, J. Natl. Cancer Inst. 57:365.
Hoover, E. A., Rojko, J. L., and Olsen, R. G., 1980, Host-virus interactions in progressive versus regressive feline leukemia virus infection in cats, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, and H. zurHausen, eds.), pp. 635–651, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Hoover, E. A., Rojko, J. L., Wilson, P. L., and Olsen, R. G., 1981, Determinants of susceptibility and resistance to feline leukemia virus infection. I: Role of macrophages, J. Natl. Cancer Inst. 67:889.
Hoover, E. A., Rojko, J. L., and Quackenbush, S. L., 1983, Congenital feline leukemia virus infection, Leuk. Rev. Intl. 1:7.
Hoover, E. A., Zeidner, N. S., Perigo, N. A., Quackenbush, S. L., Strobel, J. D., Hill, D. L., and Mullins, J. I., 1989, Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy, Intervirology 30(Suppl. 1):12.
Huang, E., Nocka, K., Beier, D. R., Chu, T-Y., Buck, J., Lahm, H-W., Wellner, D., Leder, P., and Besmer, P., 1990, The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus, Cell 63:225.
Huebner, R. J., and Todaro, G. J., 1969, Oncogenesis of RNA tumor viruses as determinants of cancer, Proc. Natl. Acad. Sci. USA 64:1087.
Irgens, K., Wyers, M., Moraillon, A., Parodi, A., and Fortuny, V., 1973, Isolement d’un virus sarcomatogene feline a partir d’un fibrosarcome spontane du chat, etude du pouvoir sarcomatogene in vivo, C. R. Acad. Sci. (Paris) 276:1783.
Jacobs, R. M., Boyce, J. T., and Kociba, G. J., 1986, Flow cytometric and radioisotopic determinations of platelet survival time in normal cats and feline leukemia virus-infected cats, Cytometry 7:64.
Jahner, P., and Haenisch, R., 1985, Chromosomal position and specific demethylation in enhancer sequences of germ-line transmitted retroviral genomes during mouse development, Mol. Cell Biol. 5:2212.
Jakowski, R. M., Essex, M., Hardy, W. D., Jr., Stephenson, J. R., and Cotter, S. M., 1980, Membranous glomerulonephritis in a household of cats persistently viremic with feline leukemia virus, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 141–149, Elsevier, New York.
Jarrett, W. F. H., Crawford, E. M., Martin, W. B., and Davie, F., 1964, A virus-like particle associated with leukemia (lymphosarcoma), Nature 202:567.
Jarrett, W. F. H., Jarrett, O., Mackey, L., Laird, H., Hardy, W. D., Jr., and Essex, M., 1973a, Horizontal transmission of leukemia virus and leukemia in the cat. J. Natl. Cancer Inst. 51:833.
Jarrett, O., Laird, H. M., and Hay, D., 1973b, Determinants of the host range of feline leukaemia viruses, J. Gen. Virol 20:169.
Jarrett, W., Mackey, L., Jarrett, O., Laird, H., and Hood, C., 1974, Antibody response and virus survival in cats vaccinated against feline leukemia, Nature 248:230.
Jarrett, O., Hardy, W. D., Jr., Golder, M. C., and Hay, D., 1978, The frequency of occurrence of feline leukemia virus subgroups in cats, Int. J. Cancer 21:334.
Jarrett, O., Golder, M. C., and Weijer, K., 1982, A comparison of three methods of feline leukaemia virus diagnosis, Vet. Kec. 110:325.
Jones, F. R., Yoshida, L. H., Ladiges, W. C., and Kenny, M. A., 1980, Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG, Cancer 46:675.
Kahn, D. E., Mia, A. S., and Tierney, M. M., 1980, Field evaluation of Leukassay F, an FeLV detection test kit, Feline Pract. 10:41.
Kensil, C. R., Barrett, C., Kushner, N., Beltz, G., Storey, J., Patel, U., Aubert, A., and Marciani, D., 1991, Development of a genetically engineered vaccine against feline leukemia virus infection, J. Am. Vet. Med. Assoc. 199:1423.
Kobilinsky, L., Hardy, W. D., Jr., and Day, N. K., 1979, Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats, J. Immunol. 122:2139.
Kociba, G. J., Lange, R. D., Dunn, C. D. R., and Hoover, E. A., 1983, Serum erythropoietin changes with feline leukemia virus-induced erythroid aplasia, Vet. Pathol. 20:548.
Koshy, R., Wong-Staal, F., Gallo, R. C., Hardy, W. D., Jr., and Essex, M., 1979, Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats, Virology 99:135.
Lafrado, L. J., and Olsen, R. G., 1986, Demonstration of depressed polymorphonuclear leukocyte function in non-viremic FeLV-infected cats, Cancer Invest. 4:297.
Lafrado, L. J., Dezzutti, C. S., Lewis, M. G., and Olsen, R. G., 1989, Immunodeficiency in latent feline leukemia virus infections, Vet. Immunol. Immunopathol. 21:39.
Lederman, L., Singhal, M. C., Besmer, P., Zuckerman, E. E., Hardy, W. D., Jr., and Snyder, H. W., Jr., 1985, Immunological and biochemical characterization of HZ2 feline sarcoma virus and Abelson murine leukemia virus translation products, J. Gen. Virol. 66:2057.
Legendre, A. M., Mitchener, K. L., and Potgieter, L. N., 1990, Efficacy of a feline leukemia virus vaccine in a natural exposure challenge, J. Vet. Intern. Med. 4:92.
Leis, J., Baltimore, D., Bishop, J. M., Coffin, J., Fleissner, E., Goff, S. P., Oroszlan, S., Robinson, H., Skalka, A. M., Temin, H. M., and Vogt, V., 1988, Standardized and simplified nomenclature for proteins common to all retroviruses, J. Virol. 62:1808.
Levesque, K. S., Bonham, L., and Levy, L. S., 1990, Flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type, J. Virol. 64:3455.
Levin, R., Ruscetti, S. F., Parks, W. P., and Scolnick, E. M., 1976, Expression of feline type-C virus in normal and tumor tissues of the domestic cat, Int. J. Cancer 18:661.
Levy, J. A., 1978, Xenotropic type-C viruses, Curr. Top. Microbiol. Immunol. 79:111.
Levy, L. S., Gardner, M. B., and Casey, J. W., 1984, Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma, Nature 308:853.
Levy, L. S., Fish, R. E., and Baskin, G. B., 1988, Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats, J. Virol. 62:4770.
Livingston, D. M., and Todaro, G. J., 1973, Endogenous type-C virus from a cat cell clone with properties distinct from previously described feline viruses, Virology 53:142.
Lutz, H., Pedersen, N. C., Harris, C. W., Higgins, B. S., and Theilen, G. H., 1980, Detection of feline leukemia virus infection, Feline Pract. 10:13.
Lyman, S. D., Park, L., and Rohrschneider, L. R., 1988, Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts, Oncogene 3:391.
Mackey, L. J., Jarrett, W., Jarrett, O., and Laird, H., 1975, Anemia associated with feline leukemia virus infection in cats, J. Natl. Cancer Inst. 54:209.
Majumder, S., Ray, P., and Besmer, P., 1990, Tyrosine protein kinase activity of the HZ-4-feline sarcoma virus P80gas-kit-transforming protein, Oncogene Res. 5:329.
Mandel, M. P., Stephenson, J. R., Hardy, W. D., Jr., and Essex, M., 1979, Endogenous RD-114 virus of cats: Absence of antibodies to RD-114 envelope antigens in cats naturally exposed to the feline leukemia virus, Infect. Immunol. 24:282.
Mastro, J. M., Lewis, M., Mathes, L. E., Sharpee, R., Tarr, M. J., and Olsen, R. G., 1986, Feline leukemia vaccine: Efficacy, contents and probable mechanism, Vet. Immunol. Immunopathol. 11:205.
Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Vande Stouwe, R. A., Holzman, R. S., Wormser, G., Brettman, L., Lange, M., Murray, H. W., and Cunningham-Rundles, S., 1981, An outbreak of community-acquired pneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction, N. Engl. J. Med. 305:1431.
Mathes, L. E., Olsen, R. G., Hebebrand, L. C., Hoover, E. A., and Schaller, J. P., 1978, Abrogation of lymphocyte blastogenesis by a feline leukemia virus protein, Nature 274:687.
McAllister, R. M., Nicolson, M., Gardner, M. B., Rongey, R. W., Rasheed, S., Sarma, P. S., Huebner, R. J., Hatanaka, M., Oroszlan, S., Gilden, R. V., Kabigting, A., and Vernon, L., 1973, RD-114 comparison with feline and murine type C viruses released from RD cells, Nature 242:75.
McClelland, A. J., Hardy, W. D., Jr., and Zuckerman, E. E., 1980, Prognosis of healthy feline leukemia virus infected cats, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 121–126, Elsevier, New York.
McCullough, B., Schaller, J., Shadduck, J. A., and Yohn, D. S., 1973, Induction of malignant melanomas associated with fibrosarcoma in gnotobiotic cats inoculated with Gardner feline fibrosarcoma virus, J. Natl. Cancer Inst. 48:1893.
McDonough, S. K., Larsen, S., Brodey, R. S., Stock, N. D., and Hardy, W. D., Jr., 1971, A transmissible feline fibrosarcoma of viral origin, Cancer Res. 31:953.
Moore, F. M., Emerson, W. E., Cotter, S. M., and DeLellis, R. A., 1986, Distinctive peripheral lymph node hyperplasia of young cats, Vet. Pathol. 23:386.
Mullins, J. I., and Hoover, E. A., 1990, Molecular aspects of feline leukemia virus pathogenesis, in: Retrovirus Biology: An Emerging Role in Human Disease (R. C. Gallo and F. Wong-Staal, eds), Marcel Dekker, New York.
Mullins, J. T., Casey, J. W., Nicolson, M. D., Burck, K. B., and Davidson, N., 1981, Sequence arrangement and biological activity of cloned feline leukemia proviruses from a virus productive human cell line, J. Virol. 38:688.
Mullins, J. T., Brody, D. S., Binari, R. C., Jr., and Cotter, S. M., 1984, Viral transduction of c-myc gene in naturally occurring feline leukaemias, Nature 308:856.
Mullins, J. T., Chen, C. S., and Hoover, E. A., 1986, Disease-specific and tissue-specific production of unintegrated feline leukemia virus variant DNA in feline AIDS, Nature 319:332.
Naharro, G., Dunn, C. Y., and Robbins, K. C., 1983, Analysis of the primary translational product and integrated DNA of a new feline sarcoma virus, GR-FeSV, Virology 125:502.
Naharro, G., Robbins, K. C., and Reddy, E. P., 1984, Gene product of v-fgr onc: Hybrid protein containing a portion of actin and a Tyrosine-specific protein kinase, Science 223:63.
Neil, J. C., Hughes, D., McFarlane, R., Wilkie, N. M., Onions, D. E., Lees, G., and Jarrett, O., 1984, Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias, Nature 308:814.
Neil, J. C., Forrest, D., Doggett, D. L., and Mullins, J. I., 1987, The role of feline leukaemia virus in naturally occurring leukaemias, Cancer Surv. 6:117.
Neil, J. C., Fulton, R., McFarlane, R., Rigby, M., Stewart, M., Terry, A., and Tzavaras, T., 1988, Receptor-mediated leukaemogenesis: Hypothesis revisited, Br. J. Cancer Suppl. 9:76.
Niederkorn, J. Y., Shadduck, J. A., Albert, D., and Essex, M., 1980, Humoral antibody response to FOCMA in feline sarcoma virus-induced ocular melanoma, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 181–185, Elsevier, New York.
Niman, H. L., Stephenson, J. R., Gardner, M. B., and Roy-Burman, P., 1977, RD-114 and feline leukemia virus genome expression in natural lymphomas of domestic cats, Nature 226:357.
Noronha, F., Grant, C. K., Lutz, H., and Keyes, A., 1983, Circulating levels of feline leukemia and sarcoma viruses and fibrosarcoma regression in persistently viremic cats, Cancer Res. 43:1663.
Nuttall, P., Pratt, R., Nuttall, L., and Daly, C., 1986, False-positive results with HIV ELISA kits, Lancet ii:512.
Okabe, H., Twiddy, E., Gilden, R. V., Hatanaka, M., Hoover, E. A., and Olsen, R. G., 1976, FeLV-related sequences in DNA from a FeLV-free cat colony, Virology 69:798.
Okabe, H., DuBuy, J., Gilden, R. V., and Gardner, M. B., 1978, A portion of the feline leukemia virus genome is not endogenous in cat cells, Int. J. Cancer 22:70.
Olsen, R. G., Hoover, E. A., Mathes, L. E., Heding, L. D., and Schaller, J. P., 1976, Immunization against feline oncornavirus disease using a killed tumor cell vaccine, Cancer Res. 36:3642.
Olsen, R. G., Lewis, M., Mathes, L. E., and Hause, W., 1980, Feline leukemia vaccine, efficacy testing in a large multicat household, Feline Pract. 10:13.
Onions, D. E., and Jarrett, O., 1987, Viral oncogenesis: Lessons from naturally occurring animal viruses, Cancer Surv. 6:161.
Onions, D., Jarrett, O., Testa, N., Frassoni, F., and Toth, S., 1982, Selective effect of feline leukaemia virus on early erythroid precursors, Nature 296:156.
Onions, D. E., Lees, G., Forrest, D., and Neil, J. C., 1987, Recombinant feline viruses containing the myc gene rapidly produce clonal tumors expressing T-cell antigen receptor gene transcripts, Int. J. Cancer 40:40.
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., and Tara, M., 1986, HTLV-I associated myelopathy, a new clinical entity, Lancet i:1031.
Osterhaus, A., Weijer, K., Uytdehaag, F., Jarrett, O., Sundquist, B., and Morein, B., 1985, Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM, J. Immunol. 135:591.
Osterhaus, A., Weijer, K., UytdeHaag, F., Knell, P., Jarrett, O., Akerblom, L., and Morein, B., 1989a, Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine, Vaccine 7:137.
Osterhaus, A. D., Rimmelzwaan, G. F., Weijer, K., and Uytdehaag, A. G., 1989b, Induction of antiviral immune response by immunization with monoclonal anti-idiotype antibodies directed to private idiotopes, Viral Immunol. 2:255.
Overbaugh, J., Donahue, P. R., Quackenbush, S. L., Hoover, E. A., and Mullins, J. I., 1988a, Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats, Science 239:906.
Overbaugh, J., Riedel, N., Hoover, E. A., and Mullins, J. I., 1988b, Transduction of endogenous envelope genes by feline leukemia virus in vitro, Nature 332:731.
Pacitti, A. M., Jarrett, O., and Hay, D., 1986, Transmission of feline leukemia virus in the milk of a non-viraemic cat, Vet. Rec. 118:381.
Pearson, L. D., Snyder, S. P., and Aldrich, C. D., 1973, Oncogenic activity of feline firbosarcoma virus in newborn pigs, Am. J. Vet. Res. 34:405.
Pedersen, N. C., and Ott, R. L., 1985, Evaluation of a commercial feline leukemia virus vaccine for immunogenicity and efficacy, Feline Pract. 15:7.
Pedersen, N. C., Theilen, G., Keane, M. A., Fairbanks, L., Mason, T., Orser, B., Chen, D-H., and Allison, C., 1977, Studies of naturally transmitted feline leukemia virus infection, Am. J. Vet. Res. 38:1523.
Pedersen, N. C., Theilen, G. H., and Werner, L. L., 1979, Safety and efficacy studies of live-and killed-feline leukemia virus vaccines, Am. J. Vet. Res. 40:1120.
Pedersen, N. C., Meric, S. M., Ho, E., Johnson, L., Plucker, S., and Theilen, G. H., 1984a, The clinical significance of latent feline leukemia virus infections in cats, Feline Pract. 14:328.
Pedersen, N. C., Johnson, L., and Theilen, G. H., 1984b, Biological behavior of tumors and associated retroviremia in cats inoculated with Snyder-Theilen fibrosarcoma virus and the phenomenon of tumor recurrence after primary regression, Infect. Immun. 43:631.
Pedersen, N. C., Ho, E. W., Brown, M. L., and Yamamoto, J. K., 1987, Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome, Science 235:790.
Pedersen, N. C., Torten, M., Rideout, B., Sparger, E., Tonachini, T., Luciw, P. A., Ackley, C., Levy, N., and Yamamoto, J., 1990, Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection, J. Virol. 64:598.
Perryman, L. E., Hoover, E. A., and Yohn, D. S., 1972, Immunologic reactivity of the cat: Immunosuppression in experimental feline leukemia, J. Natl. Cancer Inst. 49:1357.
Pierce, J. H., and Aaronson, S. A., 1983, In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus, J. Virol. 46:993.
Poiesz, B. G., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C., 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 77:7415.
Pollock, R. V., and Scarlett, J. M., 1990, Randomized blind trial of a commercial FeLV vaccine, J. Am. Vet. Med. Assoc. 196:611.
Pool, R. R., and Harris, J. M., 1975, Feline osteochondromatosis, 1975, Feline Pract. 5:24.
Poss, M. L., Mullins, J. I., and Hoover, E. A., 1989, Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus, J. Virol. 63:198.
Poss, M. L., Quackenbush, S. L., Mullins, J. I., and Hoover, E. A., 1990, Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein, J. Virol. 64:4338.
Post, J. E., and Warren, L., 1980, Reactivation of latent feline leukemia virus, in: Feline Leukemia Virus (W. D. Hardy, Jr., M. Essex, and A. J. McClelland, eds.), pp. 151–155, Elsevier, New York.
Quackenbush, S. L., Mullins, J. I., and Hoover, E. A., 1989, Colony forming T lymphocyte deficit in the development of feline retrovirus induced immunodeficiency syndrome, Blood 73:509.
Qiu, F., Ray, P., Brown, K., Barker, P. E., Jhanwar, S., Ruddle, F. H., and Besmer, P., 1990, Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus, EMBO J. 7:1003.
Rasheed, S., Barbacid, M., Aaronson, S., and Gardner, M. B., 1982, Origin and biological properties of a new feline sarcoma virus, Virology 117:238.
Reinacher, M., 1987, Feline leukemia virus-associated enteritis: A condition with features of feline panleukopenia, Vet. Pathol. 24:1.
Reynolds, F. H., Van de Ven, W. J. M., Blomberg, J., and Stephenson, J. R., 1981, Differences in mechanism of transformation by independent feline sarcoma virus isolates, J. Virol. 38:1084.
Rice, J. B., Schaller, J. P., Lewis, M. G., Mathes, L. E., Hoover, E. A., and Olsen, R. G., 1981, Infection of feline embryo adherent cells with feline leukemia virus: Feline oncornavirusassociated cell membrane antigen expression and morphologic transformation, J. Natl. Cancer Inst. 66: 89.
Rickard, C. G., Post, J. E., Noronha, F., and Barr, L. M., 1973, Interspecies infection by feline leukemia virus: Serial cell-free transmission in dogs of malignant lymphomas induced by feline leukemia virus, in: Unifying Concepts of Leukemia (R. M. Dutcher, and L. Chieco-Bianchi, eds.), pp. 102–112, Karger, Basel.
Riedel, N., Hoover, E. A., Gasper, P. W., Nicolson, M. O., and Mullins, J. I., 1986, Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-SARMA, J. Virol. 60:242.
Riedel, N., Hoover, E. A., Dornsife, R. E., and Mullins, J. I., 1988, Pathogenic and host range determinants of the feline aplastic anemia retrovirus, Proc. Natl. Acad. Sci. USA 85:2758.
Riggs, I. L., Oshiro, L. S., Taylor, D. O. N., and Lennette, E. H., 1969, Syncytium-forming agent isolated from domestic cats. Nature 222:1190.
Robbins, K. C., Antoniades, H. N., Devare, S. G., Hunkapiller, M. W., and Aaronson, S. A., 1983, Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor, Nature 305:605.
Rojko, J. L., and Hardy, W. D., Jr., 1989, Feline leukemia virus and other retroviruses, in: Diseases of the Cat: Diagnosis and Management (R. G. Sherding, ed.), pp. 229–332, Churchill Livingstone, New York.
Rojko, J. L., Hoover, E. A., Mathes, L. E., Hause, W. R., Schaller, J. P., and Olsen, R. G., 1978, Detection of feline leukemia virus in tissues of cats by a paraffin embedding immunofluorescence procedure, J. Natl. Cancer Inst. 61:1315.
Rojko, J. L., Hoover, E. A., Mathes, L. E., Olsen, R. G., and Schaller, J. P., 1979, Pathogenesis of experimental feline leukemia virus infection, J. Natl. Cancer Inst. 63:759.
Rojko, J. L., Hoover, E. A., Quackenbush, S. L., and Olsen, R. G., 1982, Reactivation of latent feline leukaemia virus infection, Nature 298:385.
Rojko, J. L., Cheney, C. M., Gasper, P. W., Hamilton, K. L., Hoover, E. A., Mathes, L. F., and Kociba, G. J., 1986, Infectious feline leukemia virus is erythrosuppression in vitro, Leukemia Res. 10:1193.
Rosenberg, Z., Pedersen, F. S., and Haseltine, W. A., 1980, Comparative analysis of the genomes of feline leukemia viruses, J. Virol. 35:542.
Roussel, M., Saule, S., Lagrou, C., Rommens, C., Beug, H., Graf, T., and Stehelin, D., 1979, Three new types of viral oncogenes of cellular origin specific for haematopoietic cell transformation, Nature 281:452.
Ruegg, C. L., Monell, C. R., and Strand, M., 1989, Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II, J. Virol. 63:3250.
Russell, P. H., and Jarrett, O., 1978, The occurrence of feline leukemia virus neutralizing antibodies in cats, Int. J. Cancer 22:351.
Sacca, R., Stanley, E. R., Sherr, C. J., and Rettenmier, C. W., 1986, Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene, Proc. Natl. Acad. Sci. USA 83:3331.
Sariban, E., Mitchell, T., and Kufe, D., 1985, Expression of the c-fms proto-oncogene during human monocyte differentiation, Nature 316:164.
Sarma, P. S., and Log, T., 1973, Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests, Virology 54:160.
Scolnick, E. M., 1982, Hyperplastic and neoplastic erythroproliferative diseases induced by oncogenic murine retroviruses, Acta Biochem. Biophys. 651:273.
Shadduck, J. A., Albert, D. M., and Niederkorn, J. Y., 1981, Feline uveal melanomas induced with feline sarcoma virus: Potential model of the human counterpart, J. Natl. Cancer Inst. 67:619.
Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. T., and Stanley, D. R., 1985, The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1, Cell 41:665.
Shibuya, M., Hanafusa, T., Hanafusa, H., and Stephenson, J. R., 1980, Homology exists among the transforming sequences of avian and feline sarcoma viruses, Proc. Natl. Acad. Sci. USA 77:6536.
Snider, W. B., Simpson, D. M., Kielsen, S., Gold, J. W. M., Metroka, C. E., and Posner, J. B., 1983, Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients, Ann. Neurol. 14:403.
Snyder, H. W., Jr., 1982, Biochemical characterization of protein kinase activities associated with transforming gene products of the Snyder-Theilen and Gardner-Arnstein strains of feline sarcoma virus, Virology 117:165.
Snyder, S. P., and Theilen, G. H., 1969, Transmissible feline fibrosarcoma, Nature 221:1074.
Snyder, H. W., Jr., Hardy, W. D., Jr., Zuckerman, E. E., and Fleissner, E., 1978, Characterization of a tumour-specific antigen on the surface of feline lymphosarcoma cells, Nature 275:656.
Snyder, H. W., Jr., Phillips, K. J., Hardy, W. D., Jr., Zuckerman, E. E., Essex, M., Sliski, A. H., and Rhim, J., 1980, Isolation and characterization of proteins carrying the feline oncornavirusassociated cell-membrane antigen, Cold Spring Harb. Symp. Quant. Biol. 44:787.
Snyder, H. W.; Jr., Jones, F. R., Day, N. K., and Hardy, W. D., Jr., 1982, Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption, J. Immunol. 128:2726.
Snyder, H. W., Jr., Singhal, M. C., Zuckerman, E. E., Jones, F. R., and Hardy, W. D., Jr., 1983, The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70, Virology 131:315.
Snyder, H. W., Jr., Singhal, M. C., Zuckerman, E. E., and Hardy, W. D., Jr., 1984a, Isolation of a new feline sarcoma virus (HZI-FeSV), Biochemical and immunological characterization of its translation product, Virology 132:205.
Snyder, H. W., Jr., Singhal, M. C., Hardy, W. D., Jr., and Jones, F. R., 1984b, Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp70, J. Immunol. 132:1538.
Soe, L. H., Devi, B. C., Mullins, J. I., and Roy-Burman, P., 1983, Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library, J. Virol. 46:829.
Soe, L. H., Shimizu, R. W., Landolph, J. R., and Roy-Burman, P., 1985, Molecular analysis of several classes of endogenous feline leukemia virus elements, J. Virol. 56:701.
Stewart, M. A., Forrest, D., McFarlane, R., Onions, D., Wilkie, N., and Neil, J. C., 1986a, Conservation of the c-myc coding sequence in transduced feline v-myc genes, Virology 154:121.
Stewart, M. A., Warnock, M., Wheeler, A., Wilkie, N., Mullins, J. I., Onions, D. E., and Neil, J. C., 1986b, Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses, J. Virol. 58:825.
Sugita, K., Gutkind, J. S., Katamine, S., Kawakami, T., and Robbins, K. C., 1989, The actin domain of Gardner-Rasheed feline sarcoma virus inhibits kinase and transforming activities, J. Virol. 63:1715.
Swenson, C. L., Kociba, G. J., Mathes, L. E., Hand, P. J., Neer, C. A., Hayes, K. A., and Olsen, R. G., 1990, Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus, J. Am. Vet. Med. Assoc. 196:1049.
Teich, N., 1982, Taxonomy of retroviruses, in: RNA Tumor Viruses (R. Weiss, N. Teich, H. Varmus, and J. Coffin, eds.), pp. 25–207, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Temin, H. M., 1988, Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses, Rev. Infect. Dis. 10:399.
Testa, N. G., Onions, D., Jarrett, O., Frassoni, F., and Eliason, J. F., 1983, Haematopoietic colony formation (BFU-E, GM-CFC) during the development of pure red cell hypoplasia induced in the cat by feline leukemia virus, Lenk. Res. 7:103.
Theilen, G. H., 1971, Continuing studies with transmissible feline fibrosarcoma virus in fetal and newborn sheep, J. Am. Vet. Med. Assoc. 158:1040.
Theilen, G. H., Kawakami, T. G., Rush, J. D., and Munn, R. J., 1969, Replication of cat leukaemia virus in cell suspension cultures, Nature 222:589.
Theilen, G. H., Snyder, S. P., Wolfe, L. G., and Landon, J. L., 1970, Biological studies with viral induced fibrosarcomas in cats, dogs, rabbits, and nonhuman primates, in: Comparative Leukemia Research 1969 (R. M. Dutcher, ed.), pp. 393–400, Karger, Basel.
Todaro, G. J., 1977, RNA tumor virus genes (virogenes) and the transforming genes (oncogenes): Genetic transmission, infectious spread, and modes of expression, in: Origins of Human Cancer (H. H. Hiatt, J. D. Watson, and J. A. Winsten, eds.), pp. 1169–1196, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Todaro, G. J., 1980, Interspecies transmission of mammalian retroviruses, in: Viral Oncology (G. Klein, ed.), pp. 291–309, Raven Press, New York.
Todaro, G. J., Benveniste, R. E., Lieber, M. M., and Livingston, D. M., 1973, Infectious type-C viruses released by normal cat embryo cells, Virology 55:506.
Todaro, G. J., Tevethia, S., and Melnick, J., 1974, Isolation of an RD-114 related type-C from feline sarcoma virus-transformed baboon cells, Intervirology 1:399.
Todaro, G. J., Benveniste, R. E., Sherwin, S. A., and Sherr, C. J., 1978, MAC-1, a new genetically transmitted type-C virus of primate: Low frequency activation from stumptail monkey cell cultures, Cell 13:775.
Tompkins, M. B., Ogilvie, G. K., Gast, A. M., Franklin, R., Weigel, R., and Tompkins, W. A., 1989, Interleukin-2 suppression in cats naturally infected with feline leukemia virus, J. Biol. Response Mod. 8:86.
Trainin, Z., Wernicke, D., Ungar-Waron, H., and Essex, M., 1983, Suppression of the humoral antibody response in natural retrovirus infections, Science 220:858.
Tzavaras, T., Stewart, M., McDougall, A., Fulton, R., Testa, N., Onions, D. E., and Neil, J. C., 1990, Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia, J. Gen. Virol. 71:343.
Vedbrat, S. S., Rasbeed, S., Lutz, H., Gonda, M. A., Ruscetti, S., Gardner, M. B., and Prensky, W., 1983, Feline oncornavirus-associated cell membrane antigen: A viral and not a cellularly coded transformation-specific antigen of cat lymphomas, Virology 124:445.
Vernant, J. C., Maurs, L., Gessain, A., Barin, F., Gout, O., Delaporte, J. M., Sanhadji, K., Buisson, G., and de-The, G., 1987, Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases, Ann. Neurol. 21:123.
Wardrop, K. J., Kramer, J. W., Abkowitz, J. L., Clemons, G., and Adamson, J. W., 1986, Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat, Am. J. Vet. Res. 47:2274.
Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, A., Westermark, B., Heldin, C-H., Huang, J. S., and Deuel, T. F., 1983, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus, Nature 304:35.
Weijer, K., and Daams, J. H., 1978, The control of lymphosarcoma/leukaemia and feline leukaemia virus, J. Small Anim. Pract. 19:631.
Weksler, M. E., Ryning, F. W., and Hardy, W. D., Jr., 1975, Immune complex disease in cancer, Clinical Bull. 5:109.
Weiler, S. K., Joy, A. E., and Temin, H. M., 1980, Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus, J. Virol. 33:494.
Wellman, M. L., Kociba, G. J., Lewis, M. G., Mathes, L. E., and Olsen, R. G., 1984, Inhibition of erythroid colony-forming cells by a 15,000 dalton protein of feline leukemia virus, Cancer Res. 44:1527.
Wellman, M. L., Kociba, G. J., Mathes, L. E., and Olsen, R. G., 1988, Suppression of feline bone marrow fibroblast colony-forming units by feline leukemia virus, Am. J. Vet. Res. 49:227.
Wong-Staal, F., and Gallo, R. C., 1985, Human T-lymphotropic retroviruses, Nature 317:395.
Yoshiki, T., Mellors, R. C., Hardy, W. D., Jr., and Fleissner, E., 1974, Common cell surface antigen associated with mammalian C-type RNA viruses, J. Exp. Med. 139:925.
Youngren, S. D., and deNoronha, F., 1983, A transmissible feline sarcoma virus containing sequences related to the K-ras one gene, in: RNA Tumor Viruses (E. Scolnick and N. Hopkins eds.), p. 33, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Ziemiecki, A., Hennig, D., Gardner, L., Ferdinand, F. J., Friis, R. R., Bauer, H., Pedersen, N. C., Johnson, L., and Theilen, G. H., 1984, Biological and biochemical characterization of a new isolate of feline sarcoma virus: Theilen-Pedersen (TP1-FeSV), Virology 138:324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hardy, W.D. (1993). Feline Oncoretroviruses. In: Levy, J.A. (eds) The Retroviridae. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1627-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1627-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1629-7
Online ISBN: 978-1-4899-1627-3
eBook Packages: Springer Book Archive